These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 22323596

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury.
    Jiang J, Yu Y, Kinjo ER, Du Y, Nguyen HP, Dingledine R.
    Neuropharmacology; 2019 May 01; 149():149-160. PubMed ID: 30763657
    [Abstract] [Full Text] [Related]

  • 4. A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in Rats.
    Rojas A, Amaradhi R, Banik A, Jiang C, Abreu-Melon J, Wang S, Dingledine R, Ganesh T.
    Neurotherapeutics; 2021 Apr 01; 18(2):1207-1225. PubMed ID: 33410110
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E, Otxoa-de-Amezaga A, Font-Nieves M, Sans-Fons MG, Planas AM.
    J Neuroinflammation; 2017 Jan 05; 14(1):3. PubMed ID: 28086956
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus.
    Jiang J, Yang MS, Quan Y, Gueorguieva P, Ganesh T, Dingledine R.
    Neurobiol Dis; 2015 Apr 05; 76():126-136. PubMed ID: 25600211
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.
    Jiang J, Quan Y, Ganesh T, Pouliot WA, Dudek FE, Dingledine R.
    Proc Natl Acad Sci U S A; 2013 Feb 26; 110(9):3591-6. PubMed ID: 23401547
    [Abstract] [Full Text] [Related]

  • 8. EP2 Receptor Signaling Regulates Microglia Death.
    Fu Y, Yang MS, Jiang J, Ganesh T, Joe E, Dingledine R.
    Mol Pharmacol; 2015 Jul 26; 88(1):161-70. PubMed ID: 25715797
    [Abstract] [Full Text] [Related]

  • 9. AH6809 decreases production of inflammatory mediators by PGE2 - EP2 - cAMP signaling pathway in an experimentally induced pure cerebral concussion in rats.
    Li P, Jiang H, Wu H, Wu D, Li H, Yu J, Lai J.
    Brain Res; 2018 Nov 01; 1698():11-28. PubMed ID: 29792868
    [Abstract] [Full Text] [Related]

  • 10. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.
    Lu JW, Wang WS, Zhou Q, Gan XW, Myatt L, Sun K.
    FASEB J; 2019 Jul 01; 33(7):8148-8160. PubMed ID: 30917001
    [Abstract] [Full Text] [Related]

  • 11. CD40 engagement on dendritic cells induces cyclooxygenase-2 and EP2 receptor via p38 and ERK MAPKs.
    Harizi H, Limem I, Gualde N.
    Immunol Cell Biol; 2011 Feb 01; 89(2):275-82. PubMed ID: 20697426
    [Abstract] [Full Text] [Related]

  • 12. Prostaglandin E2-EP2-NF-κB signaling in macrophages as a potential therapeutic target for intracranial aneurysms.
    Aoki T, Frȍsen J, Fukuda M, Bando K, Shioi G, Tsuji K, Ollikainen E, Nozaki K, Laakkonen J, Narumiya S.
    Sci Signal; 2017 Feb 07; 10(465):. PubMed ID: 28174280
    [Abstract] [Full Text] [Related]

  • 13. Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype.
    Kang X, Qiu J, Li Q, Bell KA, Du Y, Jung DW, Lee JY, Hao J, Jiang J.
    Sci Rep; 2017 Aug 25; 7(1):9459. PubMed ID: 28842681
    [Abstract] [Full Text] [Related]

  • 14. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.
    McCullough L, Wu L, Haughey N, Liang X, Hand T, Wang Q, Breyer RM, Andreasson K.
    J Neurosci; 2004 Jan 07; 24(1):257-68. PubMed ID: 14715958
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats.
    Rojas A, Ganesh T, Manji Z, O'neill T, Dingledine R.
    Neuropharmacology; 2016 Nov 07; 110(Pt A):419-430. PubMed ID: 27477533
    [Abstract] [Full Text] [Related]

  • 16. Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory Properties.
    Ganesh T, Banik A, Dingledine R, Wang W, Amaradhi R.
    Mol Pharm; 2018 Dec 03; 15(12):5809-5817. PubMed ID: 30398879
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Targeting prostaglandin receptor EP2 for adjunctive treatment of status epilepticus.
    Nagib MM, Yu Y, Jiang J.
    Pharmacol Ther; 2020 May 03; 209():107504. PubMed ID: 32088247
    [Abstract] [Full Text] [Related]

  • 19. Peripheral Myeloid Cell EP2 Activation Contributes to the Deleterious Consequences of Status Epilepticus.
    Varvel NH, Espinosa-Garcia C, Hunter-Chang S, Chen D, Biegel A, Hsieh A, Blackmer-Raynolds L, Ganesh T, Dingledine R.
    J Neurosci; 2021 Feb 03; 41(5):1105-1117. PubMed ID: 33293358
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.